Please try another search
Symbol | Exchange | Currency | ||
---|---|---|---|---|
PHAR | Amsterdam | EUR | Real-time | |
PHARMa | BATS Europe | EUR | Delayed | |
PHAR | NASDAQ | USD | Real-time | |
PHGN | Frankfurt | EUR | Delayed |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Revenue | 55.59 | 81.22 | 66.7 | 54.9 |
Gross Profit | 47.2 | 74.1 | 58.4 | 49.17 |
Operating Income | -16.31 | -15.29 | 1.9 | -15.78 |
Net Income | -12.45 | -3.12 | 3.5 | 1.32 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Total Assets | 441.67 | 462.85 | 436.47 | 429.8 |
Total Liabilities | 235.72 | 244.07 | 226.52 | 229.43 |
Total Equity | 205.94 | 218.78 | 209.94 | 200.37 |
Period Ending: | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 |
---|---|---|---|---|
Period Length: | 0 Months | 0 Months | 0 Months | 0 Months |
Cash From Operating Activities | -7.65 | 11.58 | 3.53 | -9.62 |
Cash From Investing Activities | 0.664 | -3.91 | -145.57 | 20.31 |
Cash From Financing Activities | -2.47 | -1.02 | 5.24 | -2.63 |
Net Change in Cash | -9.85 | 7.09 | -137.72 | 7.59 |
Unlock access to over 1000 metrics with InvestingPro
View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review